The regulator is considering approval of what would be the first CRISPR medicine, as well as important clearances for Alnylam, Bristol Myers, Amgen and Pfizer.
News Ticker
- [ November 30, 2023 ] Validation Engineer – PSC Biotech – Aliso Viejo, CA Los Angeles Biotech Jobs
- [ November 30, 2023 ] Atara Biotherapeutics To Present Positive New Tab-cel® Clinical Data During Oral Session at ESMO Immuno-Oncology Annual Congress 2023 Los Angeles Biotech News
- [ November 29, 2023 ] Hoag’s Cardiothoracic Surgery Team Earns Highest Distinction in Three Surgical Areas Los Angeles Biotech News
- [ November 29, 2023 ] Dr. Lauren Papa Establishes Prestigious Scholarship for Aspiring Healthcare Professionals in Los Angeles, CA Los Angeles Biotech News
- [ November 29, 2023 ] Dr. Jessica Clague DeHart of Claremont Graduate University and LYTE Foundation to receive data and findings of the important Health of Women (HOW) Study® and the Metastatic Breast Cancer Collateral Damage (MBCCD) Project Los Angeles Biotech News
Copyright © 2023 Biotech Networks, LLC
